Aprepitant recalls

The FDA has published 3 recalls involving Aprepitant since 2018. The latest was reported on 31 Dec 2025. Most were for particulate matter. Glenmark Pharmaceuticals Inc., U has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2018

Last 12 months1reported

Class I00% of total

Ongoing1latest 31 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 1 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why aprepitant is recalled

Companies

Brands

Aprepitant267%
Emend133%

By year

2025133%
2022133%
2018133%

Ongoing aprepitant recalls

1 active

Reported	Class	Recall	Company	Reason	Where
31 Dec 2025Drug	CLASS II	Merck Emend (aprepitant) for oral suspension, 125 mg recalledEmend	Merck Sharp & Dohme	Particulate Matter	Nationwide

All aprepitant recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
31 Dec 2025Drug	CLASS II	Merck Emend (aprepitant) for oral suspension, 125 mg recalledEmend	Merck Sharp & Dohme	Particulate Matter	Nationwide
15 Jun 2022Drug	CLASS II	Aprepitant Capsule, USP, 40 mg per unit dose package recalledAprepitant	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
26 Dec 2018Drug	CLASS III	Aprepitant Capsules, USP 40 mg Unit recalled by Glenmark PharmaceuticalsAprepitant	Glenmark Pharmaceuticals Inc., U	Packaging Defects	Nationwide

Should you stop taking Aprepitant?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.